Project Grant R01NS143164
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Colorado-Denver a Project Grant totaling $226,112 effective August 5, 2025, through June 30, 2030, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research initiative investigates sex-based differences in the brain macrophage response to perinatal hypoxia-ischemia (HIE), a leading cause of neonatal death and...
- Federal Project Grant Award Summary Tufts Medical Center Parent, Inc. received a $616,031 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 5, 2026, with completion targeted for February 28, 2031. This research initiative investigates the role of arterial endothelial pannexin 1 (PANX1) channels in ischemic stroke outcomes, with...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York a Project Grant of $250,328 (awarded February 6, 2026; completion January 31, 2028) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The research project investigates post-transcriptional sex differences in neurological disease by examining how RNA-binding proteins (RBPs)...
- Federal Grant Award Summary Boston Children's Hospital received a $489,500 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective March 1, 2026, through February 29, 2028. The award funds basic neuroscience research investigating the mechanistic relationship between cerebrospinal fluid (CSF) glutamate levels and choroid plexus blood-CSF barrier...
- Federal Project Grant Award Summary Augusta University Research Institute, Inc. (AURI), a non-profit research subsidiary located in Augusta, Georgia, received a $462,933 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective January 1, 2026, through December 31, 2030, supports a five-year research investigation into the molecular...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1,236,864 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, with completion scheduled for April 30, 2030. The research project, titled "Inflammasomes - A Driver of Sexual Dimorphism to Glioma Therapies," will be...
- Grant Award Summary The University of South Florida received a $568,920 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded April 17, 2026, with completion scheduled for March 31, 2031. The award funds research investigating how traumatic brain injury (TBI)-induced dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis affects...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $637,820 to the Research Institute at Nationwide Children's Hospital on June 11, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project grant supports forward genetic analysis research designed to identify novel genes influencing forebrain neurodevelopment, with specific emphasis on cortical structure, lamination, and...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $462,000 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded April 1, 2026, with completion scheduled for March 31, 2028. This research initiative investigates therapeutic strategies to mitigate brain injury and hydrocephalus in premature neonates suffering from...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University a Project Grant totaling $231,264.00 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective April 8, 2026 through March 31, 2031. This award supports research to identify and validate cerebroprotective drug targets for acute ischemic stroke by analyzing transcriptomic signatures in human blood samples...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $619,392 to Barrow Neurological Institute at St. Joseph's Hospital and Medical Center in Phoenix, Arizona, effective June 1, 2026, through May 31, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research initiative aims to molecularly deconstruct sexual dimorphism in early brain injury (EBI) following aneurysmal subarachnoid hemorrhage (ASAH) by examining cerebrospinal fluid (CSF) as a vector for neuroglial damage and developing targeted therapeutic interventions. The award supports a comprehensive research program utilizing human brain organoids (HBOs) and patient biofluids to identify molecular mediators and secreted factors contributing to EBI, with particular focus on understanding why women experience higher rates of poor outcomes. The research employs serially collected CSF samples from ASAH patients, single-cell RNA sequencing (scRNAseq), and proteomics analysis to evaluate the toxicological impact of patient CSF on human brain health modeled through three-dimensional tissue-like organoid systems. Key deliverables include quantified measurements of EBI using validated computed tomography (CT) imaging methods and the isolation and characterization of paracrine mediators that can be targeted for therapeutic development to improve patient outcomes following aneurysmal subarachnoid hemorrhage.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $619.4k | 6/3/26 |